Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8158 |
Intermediate Similarity |
NPD8240 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD6557 |
Phase 2 |
0.7424 |
Intermediate Similarity |
NPD5042 |
Phase 1 |
0.7409 |
Intermediate Similarity |
NPD3989 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD3990 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD3248 |
Phase 1 |
0.7254 |
Intermediate Similarity |
NPD4091 |
Approved |
0.7253 |
Intermediate Similarity |
NPD4939 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4092 |
Approved |
0.7165 |
Intermediate Similarity |
NPD8022 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD3995 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3994 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3992 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3991 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3996 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3993 |
Approved |
0.7121 |
Intermediate Similarity |
NPD5923 |
Phase 1 |
0.7113 |
Intermediate Similarity |
NPD3522 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7662 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD6855 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD951 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3998 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3997 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3999 |
Approved |
0.7065 |
Intermediate Similarity |
NPD979 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5856 |
Discontinued |
0.6989 |
Remote Similarity |
NPD1920 |
Approved |
0.6989 |
Remote Similarity |
NPD1919 |
Approved |
0.6973 |
Remote Similarity |
NPD4942 |
Approved |
0.6968 |
Remote Similarity |
NPD7072 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD5551 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD4412 |
Phase 2 |
0.6938 |
Remote Similarity |
NPD7817 |
Phase 1 |
0.6935 |
Remote Similarity |
NPD5748 |
Phase 2 |
0.6902 |
Remote Similarity |
NPD6017 |
Discontinued |
0.6901 |
Remote Similarity |
NPD7232 |
Discontinued |
0.6888 |
Remote Similarity |
NPD7443 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7308 |
Discontinued |
0.6837 |
Remote Similarity |
NPD1165 |
Clinical (unspecified phase) |
0.6822 |
Remote Similarity |
NPD4882 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD7014 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD5024 |
Approved |
0.6791 |
Remote Similarity |
NPD5423 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD4564 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD4565 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD7587 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD1524 |
Phase 1 |
0.6771 |
Remote Similarity |
NPD33 |
Approved |
0.6771 |
Remote Similarity |
NPD4393 |
Approved |
0.6771 |
Remote Similarity |
NPD7599 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD6613 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD8115 |
Approved |
0.6761 |
Remote Similarity |
NPD8114 |
Approved |
0.6744 |
Remote Similarity |
NPD6486 |
Approved |
0.6744 |
Remote Similarity |
NPD6487 |
Approved |
0.6743 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD7600 |
Phase 2 |
0.6732 |
Remote Similarity |
NPD7855 |
Clinical (unspecified phase) |
0.6729 |
Remote Similarity |
NPD6260 |
Discontinued |
0.6715 |
Remote Similarity |
NPD7786 |
Discontinued |
0.6714 |
Remote Similarity |
NPD2947 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD4077 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD7795 |
Phase 2 |
0.6698 |
Remote Similarity |
NPD6837 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD5839 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD8103 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD4515 |
Suspended |
0.6667 |
Remote Similarity |
NPD7572 |
Phase 2 |
0.6649 |
Remote Similarity |
NPD2790 |
Discontinued |
0.6634 |
Remote Similarity |
NPD4330 |
Approved |
0.6634 |
Remote Similarity |
NPD4329 |
Approved |
0.6632 |
Remote Similarity |
NPD4517 |
Clinical (unspecified phase) |
0.6621 |
Remote Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD6328 |
Clinical (unspecified phase) |
0.6614 |
Remote Similarity |
NPD4432 |
Discontinued |
0.6614 |
Remote Similarity |
NPD5941 |
Approved |
0.6614 |
Remote Similarity |
NPD5942 |
Approved |
0.6604 |
Remote Similarity |
NPD8050 |
Clinical (unspecified phase) |
0.6595 |
Remote Similarity |
NPD3625 |
Discontinued |
0.659 |
Remote Similarity |
NPD2443 |
Approved |
0.659 |
Remote Similarity |
NPD2442 |
Approved |
0.6589 |
Remote Similarity |
NPD3773 |
Approved |
0.6589 |
Remote Similarity |
NPD3774 |
Approved |
0.6589 |
Remote Similarity |
NPD3775 |
Approved |
0.6584 |
Remote Similarity |
NPD7771 |
Discontinued |
0.6582 |
Remote Similarity |
NPD3790 |
Phase 2 |
0.658 |
Remote Similarity |
NPD7091 |
Discontinued |
0.6577 |
Remote Similarity |
NPD2813 |
Phase 3 |
0.6577 |
Remote Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.6577 |
Remote Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.6576 |
Remote Similarity |
NPD7728 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD5989 |
Phase 1 |
0.6555 |
Remote Similarity |
NPD7569 |
Approved |
0.6555 |
Remote Similarity |
NPD7570 |
Approved |
0.6546 |
Remote Similarity |
NPD8630 |
Approved |
0.6546 |
Remote Similarity |
NPD5715 |
Clinical (unspecified phase) |
0.6542 |
Remote Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD6165 |
Phase 2 |
0.6535 |
Remote Similarity |
NPD5840 |
Discontinued |
0.6535 |
Remote Similarity |
NPD3792 |
Approved |
0.6535 |
Remote Similarity |
NPD7065 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD6164 |
Phase 2 |
0.6533 |
Remote Similarity |
NPD2369 |
Discontinued |
0.6533 |
Remote Similarity |
NPD3376 |
Clinical (unspecified phase) |
0.653 |
Remote Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.653 |
Remote Similarity |
NPD6204 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD2820 |
Phase 3 |
0.6524 |
Remote Similarity |
NPD6301 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD4988 |
Discontinued |
0.6508 |
Remote Similarity |
NPD8290 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.6504 |
Remote Similarity |
NPD5001 |
Clinical (unspecified phase) |
0.6502 |
Remote Similarity |
NPD3782 |
Discontinued |
0.6502 |
Remote Similarity |
NPD7428 |
Clinical (unspecified phase) |
0.65 |
Remote Similarity |
NPD4863 |
Approved |
0.6498 |
Remote Similarity |
NPD7568 |
Phase 1 |
0.6486 |
Remote Similarity |
NPD6655 |
Clinical (unspecified phase) |
0.6484 |
Remote Similarity |
NPD3968 |
Approved |
0.6477 |
Remote Similarity |
NPD7774 |
Clinical (unspecified phase) |
0.6477 |
Remote Similarity |
NPD2603 |
Clinical (unspecified phase) |
0.6476 |
Remote Similarity |
NPD6753 |
Phase 1 |
0.6476 |
Remote Similarity |
NPD5937 |
Approved |
0.6476 |
Remote Similarity |
NPD6752 |
Phase 1 |
0.6471 |
Remote Similarity |
NPD3227 |
Phase 2 |
0.6471 |
Remote Similarity |
NPD7225 |
Discontinued |
0.6471 |
Remote Similarity |
NPD2365 |
Approved |
0.6467 |
Remote Similarity |
NPD4782 |
Clinical (unspecified phase) |
0.6458 |
Remote Similarity |
NPD6575 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD7602 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD7552 |
Discontinued |
0.6448 |
Remote Similarity |
NPD4791 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD3246 |
Discontinued |
0.6441 |
Remote Similarity |
NPD3780 |
Phase 2 |
0.6436 |
Remote Similarity |
NPD4464 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD3805 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD3915 |
Approved |
0.6425 |
Remote Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD2590 |
Clinical (unspecified phase) |
0.6419 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.6418 |
Remote Similarity |
NPD5727 |
Clinical (unspecified phase) |
0.6415 |
Remote Similarity |
NPD7619 |
Phase 3 |
0.6415 |
Remote Similarity |
NPD7618 |
Phase 3 |
0.6414 |
Remote Similarity |
NPD2288 |
Clinical (unspecified phase) |
0.6413 |
Remote Similarity |
NPD3908 |
Approved |
0.6413 |
Remote Similarity |
NPD7970 |
Approved |
0.6413 |
Remote Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.6411 |
Remote Similarity |
NPD7175 |
Phase 1 |
0.6409 |
Remote Similarity |
NPD2408 |
Discontinued |
0.6406 |
Remote Similarity |
NPD5546 |
Clinical (unspecified phase) |
0.6402 |
Remote Similarity |
NPD7995 |
Phase 2 |
0.64 |
Remote Similarity |
NPD2037 |
Approved |
0.6396 |
Remote Similarity |
NPD3917 |
Approved |
0.6396 |
Remote Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.6396 |
Remote Similarity |
NPD7657 |
Approved |
0.6396 |
Remote Similarity |
NPD3918 |
Approved |
0.6396 |
Remote Similarity |
NPD7656 |
Approved |
0.6394 |
Remote Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.6393 |
Remote Similarity |
NPD3411 |
Phase 2 |
0.6393 |
Remote Similarity |
NPD3410 |
Approved |
0.6393 |
Remote Similarity |
NPD6740 |
Clinical (unspecified phase) |
0.6393 |
Remote Similarity |
NPD2950 |
Approved |
0.6393 |
Remote Similarity |
NPD2949 |
Approved |
0.639 |
Remote Similarity |
NPD6879 |
Phase 2 |
0.639 |
Remote Similarity |
NPD6878 |
Phase 2 |
0.6389 |
Remote Similarity |
NPD7727 |
Phase 2 |
0.6389 |
Remote Similarity |
NPD5339 |
Clinical (unspecified phase) |
0.6387 |
Remote Similarity |
NPD6631 |
Clinical (unspecified phase) |
0.6387 |
Remote Similarity |
NPD7088 |
Discontinued |
0.6384 |
Remote Similarity |
NPD3353 |
Approved |
0.6384 |
Remote Similarity |
NPD7439 |
Clinical (unspecified phase) |
0.6383 |
Remote Similarity |
NPD6768 |
Approved |
0.6382 |
Remote Similarity |
NPD7591 |
Clinical (unspecified phase) |
0.6381 |
Remote Similarity |
NPD7617 |
Discontinued |
0.638 |
Remote Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.6372 |
Remote Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.6372 |
Remote Similarity |
NPD3425 |
Discontinued |
0.6368 |
Remote Similarity |
NPD2004 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD7210 |
Clinical (unspecified phase) |
0.636 |
Remote Similarity |
NPD8311 |
Discontinued |
0.6359 |
Remote Similarity |
NPD6532 |
Discontinued |
0.6359 |
Remote Similarity |
NPD3470 |
Approved |
0.6359 |
Remote Similarity |
NPD3471 |
Approved |
0.6355 |
Remote Similarity |
NPD2461 |
Phase 1 |
0.6354 |
Remote Similarity |
NPD1781 |
Discontinued |
0.6351 |
Remote Similarity |
NPD5504 |
Discontinued |
0.6349 |
Remote Similarity |
NPD5527 |
Clinical (unspecified phase) |
0.6349 |
Remote Similarity |
NPD5526 |
Phase 2 |
0.6348 |
Remote Similarity |
NPD3622 |
Clinical (unspecified phase) |
0.6348 |
Remote Similarity |
NPD3623 |
Clinical (unspecified phase) |
0.6347 |
Remote Similarity |
NPD3967 |
Approved |
0.6343 |
Remote Similarity |
NPD6805 |
Discontinued |
0.6339 |
Remote Similarity |
NPD3632 |
Clinical (unspecified phase) |
0.6339 |
Remote Similarity |
NPD8242 |
Clinical (unspecified phase) |
0.6339 |
Remote Similarity |
NPD6481 |
Clinical (unspecified phase) |
0.6337 |
Remote Similarity |
NPD6724 |
Clinical (unspecified phase) |
0.6337 |
Remote Similarity |
NPD2431 |
Approved |
0.6337 |
Remote Similarity |
NPD2432 |
Approved |
0.6336 |
Remote Similarity |
NPD6199 |
Discontinued |
0.6335
|
Remote Similarity |
NPD5510 |
Approved |